本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

SPYRE THERAPEUTICS INC

12.71
+0.20001.60%
盘后12.710.00000.00%19:49 EDT
成交量:41.87万
成交额:529.91万
市值:7.66亿
市盈率:-4.00
高:12.92
开:12.90
低:12.33
收:12.51
数据加载中...
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/03

SEC问询函

Form CORRESP - Correspondence
2024/01/19

重要事件披露

Form 8-K - Current report
2023/12/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/22

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/12/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/24

重要事件披露

Form 8-K - Current report